Vivos Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic and Diluted
Vivos Therapeutics, Inc. (VVOS) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 21.23 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-31
- Vivos Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 23.03M shares, a 66.86% increase year-over-year.
- Vivos Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 20.83M shares, a 66.76% increase year-over-year.
- Vivos Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 20.74M shares, a 66.08% increase year-over-year.
- Vivos Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 18.21M shares, a 46.01% increase year-over-year.
- Vivos Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 21.23M shares, a 64.99% increase from fiscal 2020.
- Vivos Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 12.87M shares, a 4.36% increase from fiscal 2019.
- Vivos Therapeutics, Inc. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 12.33M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | 23.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 21.93M shares derived: average of 2 quarters · filed 2022-03-31 | 21.53M shares derived: average of 3 quarters · filed 2022-03-31 | 21.23M shares 10-K · filed 2022-03-31 | |
| 2021-09-30 | 20.83M shares 10-Q · filed 2021-11-15 | 20.78M shares derived: average of 2 quarters · filed 2021-11-15 | 20.63M shares 10-Q · filed 2021-11-15 | 18.39M shares derived: average of 4 quarters · filed 2022-03-31 | |
| 2021-06-30 | 20.74M shares 10-Q · filed 2021-08-12 | 19.48M shares 10-Q · filed 2021-08-12 | 17.58M shares derived: average of 3 quarters · filed 2022-03-31 | 16.31M shares derived: average of 4 quarters · filed 2022-03-31 | |
| 2021-03-31 | 18.21M shares 10-Q · filed 2021-05-17 | 16.01M shares derived: average of 2 quarters · filed 2022-03-31 | 14.83M shares derived: average of 3 quarters · filed 2022-03-31 | 14.25M shares derived: average of 4 quarters · filed 2022-03-31 | |
| 2020-12-31 | 13.80M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | 13.15M shares derived: average of 2 quarters · filed 2022-03-31 | 12.93M shares derived: average of 3 quarters · filed 2022-03-31 | 12.87M shares 10-K · filed 2022-03-31 | 12.87M shares 10-K · filed 2021-03-25 |
| 2020-09-30 | 12.49M shares 10-Q · filed 2021-11-15 | 12.49M shares derived: average of 2 quarters · filed 2021-11-15 | 12.56M shares 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | 12.49M shares 10-Q · filed 2021-08-12 | 12.53M shares 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | 12.47M shares 10-Q · filed 2021-05-17 | ||||
| 2019-12-31 | 12.33M shares 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |